semaglutide plateau after 1 month Weight maintenance discontinuation of GLP-1 therapies Ozempic weight loss plateau: What

Testosterone therapy induces molecular programming augmenting physiological adaptations to resistance exercise in older men

Success starts with ongoing insulin use, careful monitoring, education and regular communication with your healthcare team

These ongoing trials represent important steps toward clarifying the role of GLP-1 RAs as disease-modifying agents in PD and may pave the way for more targeted and effective therapies

Summary: Ozempic is not specifically contraindicated in Crohn's disease, but requires careful individualised assessment due to significant gastrointestinal side effects and limited clinical trial data in this population